AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « health »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
healing < health < healthcare  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000024 (2020) Joel Hirsh ; Patrick Wood ; Angela Keniston ; Dennis Boyle ; Itziar Quinzanos ; Liron Caplan ; Lisa DavisUniversal Health Literacy Precautions Are Associated With a Significant Increase in Medication Adherence in Vulnerable Rheumatology Patients
000044 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000086 (2020) Christine Brostjan ; Rudolf OehlerThe role of neutrophil death in chronic inflammation and cancer
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000118 (2020) Gregory S. Calip [États-Unis] ; Pritesh R. Patel [États-Unis] ; Karen Sweiss [États-Unis] ; Zhaoju Wu [États-Unis] ; Jifang Zhou [États-Unis] ; Alemseged A. Asfaw [États-Unis] ; Sruthi Adimadhyam [États-Unis] ; Todd A. Lee [États-Unis] ; Brian C-H Chiu [États-Unis]Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma.
000177 (2020) Kaveh Hajifathalian ; Srihari Mahadev ; Robert E. Schwartz ; Shawn Shah ; Kartik Sampath ; Felice Schnoll-Sussman ; Robert S. Brown Jr ; David Carr-Locke ; David E. Cohen ; Reem Z. SharaihaSARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
000193 (2020) Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine]Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000225 (2020) Ali Rismanbaf [Iran]Potential Treatments for COVID-19; a Narrative Literature Review
000235 (2020) Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis]Pharmacotherapy in COVID-19; A narrative review for emergency providers
000242 (2020) Colin H. Holtze [États-Unis] ; Elizabeth A. Freiheit [États-Unis] ; Susan L. Limb [États-Unis] ; John L. Stauffer [États-Unis] ; Karina Raimundo [États-Unis] ; Wayne T. Pan [États-Unis] ; Kevin R. Flaherty [États-Unis] ; Hyun J. Kim [États-Unis]Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry
000246 (2020) Christian Guder [Allemagne] ; Sascha Gravius [Allemagne] ; Christof Burger [Allemagne] ; Dieter C. Wirtz [Allemagne] ; Frank A. Schildberg [Allemagne]Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System
000249 (2020) Mark P. Lythgoe [Royaume-Uni] ; Paul Middleton [Royaume-Uni]Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
000267 (2020) Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea AntinoriNational Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000286 (2020) Tiago Torres [Portugal] ; Luis Puig [Espagne]Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
000290 (2020) Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Simone Piva [Italie] ; Nicola Latronico [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Paola Gaggia [Italie] ; Ezio Movilli [Italie] ; Sergio Bove [Italie] ; Fabio Malberti [Italie] ; Marco Farina [Italie] ; Martina Bracchi [Italie] ; Ester Maria Costantino [Italie] ; Nicola Bossini [Italie] ; Mario Gaggiotti [Italie] ; Francesco Scolari [Italie]Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
000321 (2020) Biswaranjan Paital [Inde] ; Kabita Das [Inde] ; Sarat Kumar Parida [Inde]Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
000373 (2020) Hongzhuan Xuan [République populaire de Chine] ; Aiqun Ou ; Shengyu Hao ; Jiajun Shi ; Xiaolu Jin [République populaire de Chine]Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota
000399 (2020) Gregorio Tersalvi [Suisse] ; Marco Vicenzi [Italie] ; Davide Calabretta [Italie] ; Luigi Biasco [Italie, Suisse] ; Giovanni Pedrazzini [Suisse] ; Dario Winterton [Italie]Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "health" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "health" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    health
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021